Skip to main navigation
News
Investors
Careers
Contact
About Us
Our Mission & Vision
The Zevra Story
Leadership
Board of Directors
Our Approach
What We Do
Partnering
Patients & Providers
Clinical Trials
Expanded Access Policy
Niemann-Pick Disease Type C
Sleep Disorders
Urea Cycle Disorders
Vascular Ehlers-Danlos
Products
MIPLYFFA™
OLPRUVA ®
AZSTARYS ®
Science & Pipeline
Pipeline
Clinical Trials
Publications & Presentations
Investors
Investor Relations
Events & Presentations
Stock Quote & Chart
Press Releases
Corporate Governance
SEC Filings
Contact
Email Alerts
Careers
Culture
Job Openings
Contact
info@zevra.com
888.958.1253
Facebook
Twitter
LinkedIn
Home
Menu
Menu
Event Details
Overview
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Stock Lookup
Analyst Coverage
Press Releases
Corporate Governance
Leadership
Board of Directors
Committee Composition
IRS – Required Disclosures
State Compliance
SEC Filings
Quarterly Results
Contact
Email Alerts
FAQs
Amendment to the KP415 License Agreement Conference Call
04-08-2021 4:30 PM EDT
Transcript link
Scroll to top
